Ennostar faced a loss in the fourth quarter due to inventory adjustments and the off-peak season but expects similar results in the first quarter of 2025 despite fewer working days, according to chairman Paul Peng.

administrator
Related Articles
Pharmacists Can Intervene in Commonly Overlooked Medication Errors
- September 12, 2025